Recent advancements in Graphene oxide-based for fight with HIV infection .

Recent advancements in Graphene oxide-based for fight with HIV infection .

Keywords: HIV vaccine, ERGO, PAN/GN/GCE, NH2-rGO/ β-CD/ GCE, shock and kill, immunotherapy, gene therapy



The only successful trial to date against the HIV is the RV144 trials, and today, due to the role that broadly neutralizing antibodies (bnAbs) naturally plays in the fight against the HIV, scientists are working to develop bnAbs -induced vaccines to prevent HIV infection. Electrochemical sensors along with nanomaterial’s have been tested for faster detection of the HIV in the body. Among these sensors, electrochemically reduced graphene oxide (ERGO), glassy carbon modified with polyaniline/graphene (PAN/GN/GCE), and GCE modified with amino- reduced graphene oxide (NH2)- rGO and β –cyclodextrin (β-CD) (NH2-rGO/ β-CD/ GCE) are listed in this review. Today, antiretroviral therapy (ART) and highly active antiretroviral therapy (HAART) are used to treat the HIV, which are not able to completely cure the HIV infection. The main problem with the complete elimination of the HIV is the presence of the HIV latent reservoirs in the body. To this end, several strategies have been used to completely destroy these reservoirs, including "shock and kill" therapy approach, immunotherapy, and gene therapy.

Keywords: HIV vaccine, ERGO, PAN/GN/GCE, NH2-rGO/ β-CD/ GCE, shock and kill, immunotherapy, gene therapy.


Download data is not yet available.


Sadowski and F. B. Hashemi, “Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs,” Cell. Mol. Life Sci., vol. 76, no. 18, pp. 3583–3600, Sep. 2019, doi: 10.1007/s00018-019-03156-8.
[2] C. Selinger, D. T. Dimitrov, P. A. Welkhoff, and A. Bershteyn, “The future of a partially effective HIV vaccine: assessing limitations at the population level,” Int. J. Public Health, vol. 64, no. 6, pp. 957–964, 2019, doi: 10.1007/s00038-019-01234-z.
[3] D. R. Burton, “Advancing an HIV vaccine; advancing vaccinology,” Nat. Rev. Immunol., vol. 19, no. 2, pp. 77–78, 2019, doi: 10.1038/s41577-018-0103-6.
[4] M. Stone et al., “Comparison of detection limits of fourth- and fifth-generation combination HIV antigen-antibody, p24 antigen, and viral load assays on diverse HIV isolates,” J. Clin. Microbiol., vol. 56, no. 8, pp. 1–12, 2018, doi: 10.1128/JCM.02045-17.
[5] Q. Gong et al., “Sensitive electrochemical DNA sensor for the detection of HIV based on a polyaniline/graphene nanocomposite,” J. Mater., vol. 5, no. 2, pp. 313–319, 2019, doi: 10.1016/j.jmat.2019.03.004.
[6] M. Serhan et al., “Total iron measurement in human serum with a smartphone,” AIChE Annu. Meet. Conf. Proc., vol. 2019-Novem, 2019, doi: 10.1039/x0xx00000x.
[7] M. A. Macchione, D. A. Bedoya, F. N. Figueroa, M. Á. Muñoz-Fernández, and M. C. Strumia, “Nanosystems applied to HIV infection: Prevention and treatments,” Int. J. Mol. Sci., vol. 21, no. 22, pp. 1–29, 2020, doi: 10.3390/ijms21228647.
[8] Y. Gao, P. F. McKay, and J. F. S. Mann, “Advances in HIV-1 vaccine development,” Viruses, vol. 10, no. 4, pp. 1–26, 2018, doi: 10.3390/v10040167.
[9] J. M. Steichen et al., “neutralizing antibody responses,” vol. 366, no. 6470, 2020, doi: 10.1126/science.aax4380.A.
[10] D. C. Hsu and R. J. O’Connell, “Progress in HIV vaccine development,” Hum. Vaccines Immunother., vol. 13, no. 5, pp. 1018–1030, 2017, doi: 10.1080/21645515.2016.1276138.
[11] S. Fourati et al., “Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine,” Nat. Commun., vol. 10, no. 1, pp. 1–12, 2019, doi: 10.1038/s41467-019-08854-2.
[12] K. Powezka, T. Khan, R. Narlawar, and G. A. Antoniou, “Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- company ’ s public news and information website . Elsevier hereby grants permission to make all its COVID-19-r,” no. January, 2020.
[13] D. Huang et al., “Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells,” Nat. Commun., vol. 11, no. 1, pp. 1–10, 2020, doi: 10.1038/s41467-020-19650-8.
[14] MUELLER, “乳鼠心肌提取 HHS Public Access,” Physiol. Behav., vol. 176, no. 1, pp. 139–148, 2016, doi: 10.1097/COH.0000000000000556.Neutralizing.
[15] E. R. Gray, R. Bain, O. Varsaneux, R. W. Peeling, M. M. Stevens, and R. A. McKendry, “P24 revisited: A landscape review of antigen detection for early HIV diagnosis,” Aids, vol. 32, no. 15, pp. 2089–2102, 2018, doi: 10.1097/QAD.0000000000001982.
[16] C. Liao, Y. Li, and S. C. Tjong, “Graphene nanomaterials: Synthesis, biocompatibility, and cytotoxicity,” Int. J. Mol. Sci., vol. 19, no. 11, 2018, doi: 10.3390/ijms19113564.
[17] J. Li, X. Jin, M. Feng, S. Huang, and J. Feng, “Ultrasensitive and highly selective electrochemical biosensor for HIV gene detection based on amino-reduced graphene oxide and β-cyclodextrin modified glassy carbon electrode,” Int. J. Electrochem. Sci., vol. 15, no. 3, pp. 2727–2738, 2020, doi: 10.20964/2020.03.62.
[18] A. Bowen, E. E. Sweeney, and R. Fernandes, “Nanoparticle-Based Immunoengineered Approaches for Combating HIV,” Front. Immunol., vol. 11, no. April, pp. 1–9, 2020, doi: 10.3389/fimmu.2020.00789.
[19] S. Cao and K. A. Woodrow, “Nanotechnology approaches to eradicating HIV reservoirs,” Eur. J. Pharm. Biopharm., vol. 138, pp. 48–63, 2019, doi: 10.1016/j.ejpb.2018.06.002.
[20] N. K. Rathinam, C. Saravanan, P. Parimal, V. Perumal, and M. Perumal, “Molecular interactions of graphene with HIV-Vpr, Nef and Gag proteins: A new approach for treating HIV infections,” Korean J. Chem. Eng., vol. 31, no. 5, pp. 744–747, 2014, doi: 10.1007/s11814-014-0049-8.
[21] D. Iannazzo et al., “Graphene Quantum Dots Based Systems As HIV Inhibitors,” Bioconjug. Chem., vol. 29, no. 9, pp. 3084–3093, 2018, doi: 10.1021/acs.bioconjchem.8b00448.
[22] 2016 Rooks, M.G and Garrett, W.S, “乳鼠心肌提取 HHS Public Access,” Physiol. Behav., vol. 176, no. 3, pp. 139–148, 2017, doi: 10.1097/QAD.0000000000001331.A.
[23] S. Hyun, S. B. Johnson, and S. Bakken, “Targeting the latent reservoir for HIV-1 Srona,” vol. 27, no. 4, pp. 215–225, 2015, doi: 10.1016/j.immuni.2018.04.030.Targeting.
[24] H. Mohamed, V. Miller, S. R. Jennings, B. Wigdahl, and F. C. Krebs, “The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook,” J. Immunol. Res., vol. 2020, 2020, doi: 10.1155/2020/9470102.
[25] L. T. da Silva, B. T. Santillo, A. de Almeida, A. J. da S. Duarte, and T. M. Oshiro, “Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?,” Front. Immunol., vol. 9, no. December, p. 2993, 2018, doi: 10.3389/fimmu.2018.02993.
[26] A. V. Campos Coelho et al., “Dendritic cell-based immunotherapies to fight HIV: How far from a success story? a systematic review and meta-analysis,” Int. J. Mol. Sci., vol. 17, no. 12, pp. 1–15, 2016, doi: 10.3390/ijms17121985.
[27] A. Martín-Moreno and M. A. Muñoz-Fernández, “Dendritic cells, the double agent in the war against hiv-1,” Front. Immunol., vol. 10, no. OCT, pp. 1–20, 2019, doi: 10.3389/fimmu.2019.02485.
[28] J. Kristoff, C. R. Rinaldo, and R. B. Mailliard, “Role of dendritic cells in exposing latent HIV-1 for the kill,” Viruses, vol. 12, no. 1, 2019, doi: 10.3390/v12010037.
[29] 2016 Rooks, M.G and Garrett, W.S, “乳鼠心肌提取 HHS Public Access,” Physiol. Behav., vol. 176, no. 3, pp. 139–148, 2017, doi: 10.1097/COH.0000000000000284.CELL.
[30] G. D. N. Sanches-Da-Silva, L. F. S. Medeiros, and F. M. Lima, “The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy,” Int. J. Genomics, vol. 2019, 2019, doi: 10.1155/2019/8458263.

[31] SM Mousavi, SA Hashemi, Y Ghasemi, AM Amani, A Babapoor,2019 Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study.
[32] SA Hashemi, SM Mousavi, R Faghihi, M Arjmand, S Sina, AM Amani 2018. Lead oxidedecorated graphene oxide/epoxy composite towards X-Ray radiation shielding.
[33] SM Mousavi, SA Hashemi, M Arjmand, AM Amani, F Sharif, S Jahandideh 2018. Octadecyl amine functionalized Graphene oxide towards hydrophobic chemical resistant epoxy Nanocomposites.
[34] SM Mousavi, S Soroshnia, SA Hashemi, A Babapoor, Y Ghasemi 2019. Graphene nanoribbon based high potential and efficiency for DNA, cancer therapy and drug delivery applications
[35] SA Hashemi, SM Mousavi, S Bahrani, S Ramakrishna, A Babapoor 2020. Coupled graphene oxide with hybrid metallic nanoparticles as potential electrochemical biosensors for precise detection of ascorbic acid within blood.
[36] M Mousavi, A Hashemi, O Arjmand, AM Amani, A Babapoor, MA Fateh 2018.
Erythrosine adsorption from aqueous solution via decorated graphene oxide with magnetic iron oxide nano particles: kinetic and equilibrium studies.
[37] SA Hashemi, NGG Behbahan, S Bahrani, SM Mousavi, A Gholami 2021. Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/nonbiological media .
[38] SR Rouhollah Azhdari, Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi 2019.
Decorated Graphene with Aluminum Fumarate Metal Organic Framework as a Superior NonToxic Agent for Efficient Removal of Congo Red Dye from Wastewater.
[39] SM Mousavi, FW Low, SA Hashemi, NA Samsudin, M Shakeri, Y Yusoff 2020. Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy.
[40] SR Seyyed Alireza Hashemi,Seyyed Mojtaba Mousavi,Sonia Bahrani 2020. Integrated polyaniline with graphene oxide-iron tungsten nitride nanoflakes as ultrasensitive electrochemical sensor for precise detection of 4-nitrophenol within aquatic media.
[41] SA Hashemi, SM Mousavi, R Faghihi, M Arjmand, M Rahsepar, S Bahrani 2020. Superior
X-ray Radiation Shielding Effectiveness of Biocompatible Polyaniline Reinforced with Hybrid Graphene Oxide-Iron Tungsten Nitride Flakes.
[42] A Abdollahifar, SA Hashemi, SM Mousavi, M Rahsepar 2019. Electromagnetic interference shielding effectiveness of reinforced composite with graphene oxide-lead oxide hybrid nanosheets.
[43] A Abdollahifar, SA Hashemi, SM Mousavi, M Rahsepar, AM Amani 2018. Fabrication of graphene oxide‐lead oxide epoxy based composite with enhanced chemical resistance, hydrophobicity and thermo‐mechanical properties.
[44] SM Mousavi, A Babapoor, SA Hashemi, B Medi 2020. Adsorption and removal characterization of nitrobenzene by graphene oxide coated by polythiophene nanoparticles.
[45] SR Seyyed Alireza Hashemi, Seyyed Mojtaba Mousavi, Hamid Reza Naderi, Sonia 2021.
Reinforced Polypyrrole with 2D Graphene Flakes Decorated with Interconnected Nickel-Tungsten Metal Oxide Complex Toward Superiorly Stable Supercapacitor.
[46] SM Mousavi, FW Low, SA Hashemi, L Chin Wei, Y Ghasemi 2020. Development of Graphene based Nanocomposites Towards Medical and Biological Applications.
[47]WHC Seyyed Alireza Hashemi, Seyyed Mojtaba Mousavi, Sonia Bahrani, Navid 2021. Decorated Graphene Oxide Flakes with Integrated Complex of 8-Hydroxyquinoline/NiO Toward Accurate Detection of Glucose at Physiological Conditions .
[48]SMM Najmeh Parvain,Aziz Babapoor,Ali Nematollahzadeh 2020 . Removal of phenol and β-naphthol from aqueous solution by decorated graphene oxide with magnetic iron for modified polyrhodanine as nanocomposite adsorbents: Kinetic, equilibrium and thermodynamic studies.
[49] SM Mousavi, G Behbudi, SA Hashemi, A Babapoor, WH Chiang 2021. Recent Progress in Electrochemical Detection of Human Papillomavirus (HPV) via Graphene-Based Nanosensors.

[50] AM Amani, SA Hashemi, SM Mousavi, SM Abrishamifar, A Vojood 2017.Electric field induced alignment of carbon nanotubes: methodology and outcomes.
How to Cite
JAVANMARDI N. Recent advancements in Graphene oxide-based for fight with HIV infection . AANBT [Internet]. 20Dec.2021 [cited 23Sep.2021];:47-2. Available from: